文献速递流行病学与生物统计医学教育与科研方法

SARS-CoV-2疫苗试验参与者的动机是什么?参与前后问卷调查比较研究

What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study.
PubMed 文献 · Trials · 2024-11-06

本研究为横断面观察性研究,对SARS-CoV-2疫苗临床试验参与者在参与试验前后各进行一次问卷调查,主要结局为参与动机与决策因素及前后调查差异。问卷应答率为149/200(75%)。参与者动机主要为希望为科学做贡献和帮助他人。试验前后答案无统计学差异,提示不存在回忆偏倚。

要点

  • SARS-CoV-2疫苗试验参与者的主要动机是希望为科学做贡献和帮助他人。
  • 试验前后问卷答案无统计学差异,提示不存在回忆偏倚。
  • 临床研究参与者的决策过程复杂且多层面。

核心结论

  • SARS-CoV-2疫苗试验参与者的决策过程复杂且多层面;本调查中参与者的混合动机程度超过既往研究报道。
  • 试验前后问卷答案无统计学差异,提示不存在回忆偏倚。
  • 作者提出一个理论框架,试图解释不同动机因素如何促成决策形成。

研究设计与样本

  • 横断面观察性研究。
  • 对SARS-CoV-2疫苗临床试验参与者在参与试验前和参与试验后各进行一次问卷调查。
  • 问卷应答率为149/200(75%)。
  • 主要结局为SARS-CoV-2疫苗试验参与者的动机与决策因素,以及试验前后调查的差异。

主要发现

  • SARS-CoV-2疫苗试验参与者主要因希望为科学做贡献和帮助他人而受到激励。
  • 试验前后收集的答案无统计学差异,提示不存在回忆偏倚。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Scientific advancement, including the testing and licensing of new drugs, relies heavily on clinical trials with healthy individuals. The motivations of clinical trial participants have been discussed intensively, as some worry that financial compensation may distract from the intrinsic risk of clinical research. Herein, we investigated the motivations and decisional factors influencing SARS-CoV-2 clinical trial participants. Moreover, since most surveys are administered after clinical trial participation, we were interested in whether the results were tainted by recall bias. METHODS: This was a cross-sectional observational study. Participants were administered a survey on two occasions, once before and once after participation in a clinical trial. The primary outcomes were the motivations and decisional factors of SARS-CoV-2 vaccine trial participants and the difference between the surveys collected before and after clinical trial participation. RESULTS: The survey response rate was 149/200 (75%). SARS-CoV-2 vaccine trial participants were mostly motivated by the desire to contribute to science and help others. Answers collected before and after the trial were not statistically different, indicating the absence of recall bias. CONCLUSION: The decision-making process of clinical trial participants is complex and multi-faceted. Previous studies have shown that clinical trial participants have mixed motivations but never to the extent reported in the current survey. Here, we present a theoretical framework that attempts to explain how different motivational factors may contribute to decision forming.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lamers OAC, Roestenberg M, de Vries MC, et al. What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study. Trials. 2024. PMID: 39506878. doi:10.1186/s13063-024-08582-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。